Issue 2/2014

Monitoring of minimal residual disease in acute leukemia by multiparametric flow cytometry (119 — 127)

J. KUSENDA, M. FAJTOVA, A. KOVARIKOVA

DOI: 10.4149/neo_2014_017

Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis (128 — 135)

X. LI, H. LIU, T. YU, Z. DONG, L. TANG, X. SUN

DOI: 10.4149/neo_2014_018

Inhibition of MEK sensitizes gastric cancer cells to TRAIL-induced apoptosis (136 — 143)

P. WU, Y. W. CHENG, J. Y. WANG, X. D. ZHANG, L. J. ZHANG

DOI: 10.4149/neo_2014_019

Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1 (144 — 152)

J. LI, G. H. HU, F. J. KONG, K. M. WU, B. HE, K. SONG, W. J. SUN

DOI: 10.4149/neo_2014_020

CD133 positive cells isolated from A549 cell line exhibited high liver metastatic potential (153 — 160)

H. ZHANG, N. YANG, B. SUN, Y. JIANG, C. HOU, C. JI, Y. ZHANG, Y. LIU, P. ZUO

DOI: 10.4149/neo_2014_021

Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study (161 — 169)

L. CAPKOVA, L. KOUBKOVA, R. KODET

DOI: 10.4149/neo_2014_031

Molecular alterations of the WWOX gene in nasopharyngeal carcinoma (170 — 176)

Z. YANG, H. LAN, X. CHEN, P. LI, S. LI, W. MO, A. TANG

DOI: 10.4149/neo_2014_023

Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients (177 — 185)

Z. LIU, W. DAI, L. JIANG, Y. CHENG

DOI: 10.4149/neo_2014_016

Autophagy inhibition enhances pan-Bcl-2 inhibitor AT-101-induced apoptosis in non-small cell lung cancer (186 — 192)

H. MEI, Z. LIN, Y. WANG, G. WU, Y. SONG

DOI: 10.4149/neo_2014_024

Transcriptome profiling of malignant transformed rat hepatic stem-like cells by aflatoxin B1 (193 — 204)

L. YANG, J. JI, Z. CHEN, H. WANG, J. LI

DOI: 10.4149/neo_2014_025

Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome (205 — 212)

G. TRIPSIANIS, E. PAPADOPOULOU, K. ANAGNOSTOPOULOS, S. BOTAITIS, M. KATOTOMICHELAKIS, K. ROMANIDIS, E. KONTOMANOLIS, I. TENTES, A. KORTSARIS

DOI: 10.4149/neo_2014_026

Prognostic significance of TMPRSS4 in gastric cancer (213 — 217)

H. SHENG, W. SHEN, J. ZENG, L. XI, L. DENG

DOI: 10.4149/neo_2014_027

Value of alpha-fetoprotein and clinical characteristics in patients with liver neoplasm (218 — 224)

J. B. XU, F. Z. QI, G. XU, G. F. CHEN, L. X. QIN, J. H. ZHANG

DOI: 10.4149/neo_2014_028

Efficacy of a pegaspargase-based regimen in the treatment of newly-diagnosed extranodal natural killer/T-cell lymphoma (225 — 232)

L. LI, C. ZHANG, L. ZHANG, X. LI, J. J. WU, Z. C. SUN, X. R. FU, X. H. WANG, Y. CHANG, R. WANG, Y. J. QIU, M. Z. ZHANG

DOI: 10.4149/neo_2014_029

Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancer (233 — 240)

H. IMAI, T. TAKAHASHI, K. MORI, A. ONO, H. AKAMATSU, T. SHUKUYA, T. TAIRA, H. KENMOTSU, T. NAITO, H. MURAKAMI, M. ENDO, T. NAKAJIMA, N. YAMAMOTO

DOI: 10.4149/neo_2014_030